Ovintiv Inc. (OVV): one to watch?

Not really a "crash" story — OVV is near its multi-year high with improving fundamentals; the 86% drop shown is stale history from the 2008 oil-price peak.

👀 WATCH Fundamentals70/100

Down 87% from its all-time high of $470.50 — now $63.13

$64.6$29.8 20222023202420252026

Why OVV dropped

The -86.6% figure is versus an all-time high set in 2008 (back when this company was Encana, before a 2020 rebrand and major restructuring) — it is not a recent decline. Ovintiv is currently trading at its 30-day and near 52-week high after reporting strong operational execution across its Permian and Montney assets that generated $682 million in free cash flow and enabled a $3.4 billion reduction in net debt during the quarter, plus plans to increase shareholder returns to more than 60% of annual free cash flow.

Fwd P/E 8.7Op margin 36.2%Rev growth 29.7%Debt/equity 43.7%Analyst upside 13.8%
How this scored 70/100
✅ Passes all 4 hard checks — profitable, cash-generative, and financially survivable.
✅ Makes money Net profit margin 9.7%
✅ Generates cash Free cash flow $1.2B
✅ Not drowning in debt Debt/equity 43.7% (limit 200%)
✅ Can pay its bills Current ratio 1.0 (needs 1+)

Bar length shows how much each metric is worth — a 10-point metric is twice as wide as a 5-point one. Hover any row for what it means.

Profitability Does it actually make money? 14/25
Operating margin 36.2% 9/9
Net profit margin 9.7% 4/8
Return on equity 8.4% 1/8
Growth Is it getting bigger, or dying? 25/25
Revenue growth 29.7% 9/9
Earnings growth 37.3% 8/8
Expected profit change 101.6% 8/8
Value Is it cheap right now? 15/25
Forward P/E 8.7 10/10
PEG ratio 1.9 4/8
Analyst target upside 13.8% 2/7
Balance sheet Will it survive? 16/25
Debt / equity 43.7% 9/10
Current ratio 1.0 0/8
Free cash flow $1.2B 7/7

🔒 Read the full AI analysis

Create a free account to unlock the bull case and the risks for OVV — plus today's other picks.

Analysis generated by SmartStonks's AI from public fundamentals and news, first flagged 2026-07-27. Research only — not financial advice.